Your browser doesn't support javascript.
loading
A review on the role of LINC01133 in cancers.
Ghafouri-Fard, Soudeh; Khoshbakht, Tayyebeh; Hussen, Bashdar Mahmud; Taheri, Mohammad; Mokhtari, Majid.
Afiliação
  • Ghafouri-Fard S; Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Khoshbakht T; Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Hussen BM; Department of Pharmacognosy, College of Pharmacy, Hawler Medical University, Kurdistan Region, Erbil, Iraq.
  • Taheri M; Institute of Human Genetics, Jena University Hospital, Jena, Germany. Mohammad.taheri@uni-jena.de.
  • Mokhtari M; Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Mohammad.taheri@uni-jena.de.
Cancer Cell Int ; 22(1): 270, 2022 Aug 30.
Article em En | MEDLINE | ID: mdl-36042493
ABSTRACT
Long Intergenic Non-Protein Coding RNA 1133 (LINC01133) is a long non-coding RNA (lncRNA) which interacts with miR-106a-3p, miR-576-5p, miR-495-3p, miR-205, miR-199a-5p, miR-4784, miR-30a-5p, miR-199a, miR-30b-5p, miR-216a -5p and miR-422a, thus increasing expression of mRNA targets of these miRNAs. LINC01133 can affect cancer metastasis through regulation of epithelial-mesenchymal transition program. Dysregulation of this lncRNA has been repeatedly detected in the process of tumorigenesis. In this review, we summarize the results of various studies that reported dysregulation of LINC01133 in different samples and described the role of this lncRNA as a marker for these disorders.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article